Literature DB >> 16893811

Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats.

Claes E G Lundgren1, Guri W Bergoe, Ingvald M Tyssebotn.   

Abstract

It has earlier been hypothesized that intravascular microbubbles, derived from a dodecafluoropentane (DDFP) emulsion, can transport physiologically significant amounts of oxygen in the animal body. To test this notion, anesthetized oxygen breathing rats were rendered severely anemic by bleeding and volume replacement. Rats treated with 0.014 ml/kg of DDFP in a 2% emulsion had normal circulatory parameters and behaved normally when waking up from anesthesia while controls died during anesthesia. Oxygen-breathing intact rats given 0.01 ml/kg of DDFP had muscle oxygen tensions which, for about 2.5 hours, exceeded those of controls by 50-100%. It was further verified in vitro that DDFP-derived microbubbles can exchange oxygen with a surrounding aqueous medium. Extrapolation from these experiments indicates that less than 1 ml of DDFP, in emulsion-form, could provide for the resting oxygen consumption of an adult person. This suggests various therapeutic uses of the emulsion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893811     DOI: 10.1080/10731190600769271

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  9 in total

1.  Dodecafluoropentane emulsion decreases infarct volume in a rabbit ischemic stroke model.

Authors:  William C Culp; Sean D Woods; Robert D Skinner; Aliza T Brown; John D Lowery; Jennifer L H Johnson; Evan C Unger; Leah J Hennings; Michael J Borrelli; Paula K Roberson
Journal:  J Vasc Interv Radiol       Date:  2011-11-12       Impact factor: 3.464

2.  Imaging assessment of cardioprotection mediated by a dodecafluoropentane oxygen-carrier administered during myocardial infarction.

Authors:  Zhonglin Liu; Christy Barber; Akash Gupta; Li Wan; Young-Wook Won; Lars R Furenlid; Qin Chen; Ankit A Desai; Ming Zhao; David A Bull; Evan C Unger; Diego R Martin
Journal:  Nucl Med Biol       Date:  2019-01-17       Impact factor: 2.408

Review 3.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

Review 4.  Perspective on ultrasound bioeffects and possible implications for continuous post-dive monitoring safety.

Authors:  Erica P McCune; David Q Le; Peter Lindholm; Kathryn R Nightingale; Paul A Dayton; Virginie Papadopoulou
Journal:  Diving Hyperb Med       Date:  2022-06-30       Impact factor: 1.228

5.  Progress in dodecafluoropentane emulsion as a neuroprotective agent in a rabbit stroke model.

Authors:  S D Woods; R D Skinner; A M Ricca; A T Brown; J D Lowery; M J Borrelli; J O Lay; W C Culp
Journal:  Mol Neurobiol       Date:  2013-06-28       Impact factor: 5.590

6.  Dodecafluoropentane Emulsion (DDFPe) Decreases Stroke Size and Improves Neurological Scores in a Permanent Occlusion Rat Stroke Model.

Authors:  A T Brown; M C Arthur; J S Nix; J A Montgomery; R D Skinner; P K Roberson; Michael Borrelli; W C Culp
Journal:  Open Neurol J       Date:  2014-12-30

Review 7.  Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging.

Authors:  Terry O Matsunaga; Paul S Sheeran; Samantha Luois; Jason E Streeter; Lee B Mullin; Bhaskar Banerjee; Paul A Dayton
Journal:  Theranostics       Date:  2012-12-23       Impact factor: 11.556

8.  Theranostic oxygen delivery using ultrasound and microbubbles.

Authors:  James J Kwan; Mehmet Kaya; Mark A Borden; Paul A Dayton
Journal:  Theranostics       Date:  2012-12-23       Impact factor: 11.556

9.  Dodecafluoropentane emulsion elicits cardiac protection against myocardial infarction through an ATP-Sensitive K+ channel dependent mechanism.

Authors:  Joshua Strom; Trevor Swyers; David Wilson; Evan Unger; Qin M Chen; Douglas F Larson
Journal:  Cardiovasc Drugs Ther       Date:  2014-12       Impact factor: 3.727

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.